Literature DB >> 6978968

Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome.

M Barthels, J Edel, B Liese, H E Karges.   

Abstract

Factor XII plasma levels were investigated with several methods in patients with hemophilia A and B and von Willebrand syndrome. There seem to be some families with hemophilia A or von Willebrand syndrome, who have an additional, congenital, partial lack of factor XII (Hageman factor). The mode of inheritance is independent of the other coagulation disorder. Frequently, the first indication of an additional factor XII deficiency is the disproportionate prolongation of the activated partial thromboplastin time (PTT) as regards the factor VIII level. The average factor XII level in patients with hemophilia A and von Willebrand syndrome is significantly lower than in normal subjects or patients with hemophilia B. It cannot be excluded that the frequently low levels of factor XII in patients with severe hemophilia are acquired and probably due to liver cell damage.

Entities:  

Mesh:

Year:  1982        PMID: 6978968     DOI: 10.1007/BF01716807

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  20 in total

1.  [Investigation into a family with factor XI deficiency and Willebrand-Jürgens syndrome].

Authors:  H Plendl; W Grote
Journal:  Med Welt       Date:  1979-08-24

2.  Fletcher factor deficiency: family study and detection.

Authors:  C F Abildgaard; J Harrison
Journal:  Blood       Date:  1974-05       Impact factor: 22.113

3.  Congenital combined factor V and factor VIII deficiency in a male born from a brother-sister incest.

Authors:  A Girolami; A Brunetti; L De Marco
Journal:  Blut       Date:  1974-01

Review 4.  Detection of the carrier state in hereditary coagulation disorders. II.

Authors:  J J Veltkamp; E F Drion; E A Loeliger
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31

5.  Congenital deficiency of Hageman factor (clotting factor XII). Report on the first two families found in Switzerland.

Authors:  R Baumann; P W Straub
Journal:  Helv Med Acta       Date:  1968-11

6.  Hageman factor (factor XII) in an affected kindred and in normal adults.

Authors:  C K Kasper; D Y Whissell; P M Aggeler
Journal:  Br J Haematol       Date:  1968-05       Impact factor: 6.998

7.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

8.  Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.

Authors:  R A Marlar; J H Griffin
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Congenital combined factor VII and factor VIII deficiency.

Authors:  S J Machin; B R Miller
Journal:  Acta Haematol       Date:  1980       Impact factor: 2.195

10.  The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant.

Authors:  P M Mannucci; M T Canciani; D Mari; P Meucci
Journal:  Scand J Haematol       Date:  1979-05
View more
  2 in total

1.  The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophilia.

Authors:  M Köhler; P Hellstern; B Reiter; G von Blohn; E Wenzel
Journal:  Klin Wochenschr       Date:  1984-06-01

Review 2.  The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature.

Authors:  A Girolami; M L Randi; S Gavasso; A M Lombardi; F Spiezia
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.